Citation Tools
PDFResearch ethics
The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: a case study
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: a case study
Other content recommended for you
- Variations in institutional review board processes and consent requirements for trauma research: an EAST multicenter survey
- When are clinical trials beneficial for study patients and future patients? A factorial vignette-based survey of institutional review board members
- ‘Ethical responsibility’ or ‘a whole can of worms’: differences in opinion on incidental finding review and disclosure in neuroimaging research from focus group discussions with participants, parents, IRB members, investigators, physicians and community members
- A qualitative study of institutional review board members’ experience reviewing research proposals using emergency exception from informed consent
- How IRBs view and make decisions about coercion and undue influence
- Ethics committees for biomedical research in some African emerging countries: which establishment for which independence? A comparison with the USA and Canada
- Clinical research with economically disadvantaged populations
- Leveraging artificial intelligence to detect ethical concerns in medical research: a case study
- Developing capacity to protect human research subjects in a post-conflict, resource-constrained setting: procedures and prospects
- How US institutional review boards decide when researchers need to translate studies